Johnson & Johnson to acquire Abiomed, a company that helps your heart pump blood
This will be the largest MedTech and BioTech transaction of 2022. Johnson & Johnson (J&J), one of the world’s largest producers of medical devices, announced it will acquire Abiomed Inc. for around $17.3 billion in cash and will pay $380 for each Abiomed share, a 50.7 per cent premium over its closing price of $252.08, […]
Continue with Facebook Continue with Google